
Pulmonologist David Hill, MD, anticipates cytisinicline's approval ahead of its June 20 PDUFA date.

Chair, American Lung Association Board of Directors, Director of Clinical Research at Waterbury Pulmonary Associates, and assistant clinical professor of medicine at Yale University School of Medicine and Quinnipiac University.